No-Rofecoxib

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for No-Rofecoxib, covering 2015-06-02 to 2015-06-02. Get the full timeline:

Most recent: Clinical Trial Update: 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003) [Phase 2]